ReviewCancers2021

CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.

Michela Roberto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.